Affimed Announces Second Quarter 2017 Financial Results and Corporate Update Conference Call July 25, 2017
Affimed Presents Data on First-in-Class BCMA-Targeting Immune Cell Engager AFM26 at ASCO Annual Meeting 2017 June 6, 2017
Affimed to Present Immune Cell Engager Data at ASCO Annual Meeting and EACR-AACR-SIC Special Conference May 17, 2017
